| __timestamp | Arrowhead Pharmaceuticals, Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 15879000000 |
| Thursday, January 1, 2015 | 382000 | 16560000000 |
| Friday, January 1, 2016 | 158333 | 19427000000 |
| Sunday, January 1, 2017 | 31407709 | 20776000000 |
| Monday, January 1, 2018 | 16142321 | 22561000000 |
| Tuesday, January 1, 2019 | 168795577 | 26145000000 |
| Wednesday, January 1, 2020 | 87992066 | 42518000000 |
| Friday, January 1, 2021 | 138287000 | 46385000000 |
| Saturday, January 1, 2022 | 243231000 | 46159000000 |
| Sunday, January 1, 2023 | 240735000 | 45006000000 |
| Monday, January 1, 2024 | 3551000 | 48300000000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, revenue performance is a key indicator of success. Over the past decade, Bristol-Myers Squibb Company (BMY) and Arrowhead Pharmaceuticals, Inc. (ARWR) have showcased contrasting revenue trajectories.
Bristol-Myers Squibb, a giant in the industry, consistently reported robust revenues, peaking at approximately $46 billion in 2021. This represents a remarkable 192% increase from 2014. In contrast, Arrowhead Pharmaceuticals, a smaller player, experienced a more volatile journey. Despite starting with modest revenues, Arrowhead saw a significant surge, reaching its highest point in 2022 with a 1,390% increase from 2014.
While Bristol-Myers Squibb's revenue growth reflects stability and market dominance, Arrowhead's trajectory highlights its potential for rapid expansion. However, the data for 2024 remains incomplete, leaving room for speculation on future trends.
Breaking Down Revenue Trends: Eli Lilly and Company vs Bristol-Myers Squibb Company
Annual Revenue Comparison: Novo Nordisk A/S vs Bristol-Myers Squibb Company
Novo Nordisk A/S vs Arrowhead Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Revenue Insights: AstraZeneca PLC and Arrowhead Pharmaceuticals, Inc. Performance Compared
Revenue Insights: Bristol-Myers Squibb Company and Zoetis Inc. Performance Compared
Bristol-Myers Squibb Company or GSK plc: Who Leads in Yearly Revenue?
Bristol-Myers Squibb Company or Sarepta Therapeutics, Inc.: Who Leads in Yearly Revenue?
Bristol-Myers Squibb Company and TG Therapeutics, Inc.: A Comprehensive Revenue Analysis
Bristol-Myers Squibb Company vs Xencor, Inc.: Examining Key Revenue Metrics
Breaking Down Revenue Trends: Zoetis Inc. vs Arrowhead Pharmaceuticals, Inc.
PTC Therapeutics, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Arrowhead Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Examining Key Revenue Metrics